key: cord-0031969-2ptqk14l authors: Vellin, J.-F.; Mazouzi, S.; Rubin, F. title: Time to surgery after Covid infection: Changes to the guidelines of the French Society of Anesthesia and Intensive Care Medicine (SFAR) date: 2022-05-20 journal: Eur Ann Otorhinolaryngol Head Neck Dis DOI: 10.1016/j.anorl.2022.04.003 sha: 0a487962f2f62395c7d9eb221e353b57308ae340 doc_id: 31969 cord_uid: 2ptqk14l nan Dear Editor-in-Chief, A recent article in your journal stressed the risks of surgery following Covid infection and advised an interval of 7 weeks other than in emergencies, due to added risk of postoperative respiratory and non-respiratory complications, even in asymptomatic patients [1] . In this context, we wish to draw your readers' attention to the conclusions of two position papers published by the French Society of Anesthesia and Intensive Care Medicine (SFAR) in January 2022: [https://sfar.org/positionnement-de-la-sfar-sur-le-delai-dereport-dune-intervention-programmee-apres-test-de-depistagepreoperatoire-positif/ and https://sfar.org/positionnement-de-lasfar-sur-la-place-des-tests-antigeniques-tag-sars-cov-2-pour-ledepistage-pre-interventionnel/]. The first [https://sfar.org/positionnement-de-la-sfar-sur-ledelai-de-report-dune-intervention-programmee-apres-test-dedepistage-preoperatoire-positif/] deals with the preoperative wait time in case of Covid infection. The SFAR now recommends reducing this to 4 weeks (i.e., scheduling as of week 5) after a Fig. 1 . Algorithm for SARS-CoV-2 screening test before surgery. Source: SFAR https://sfar.org/positionnement-de-la-sfar-sur-la-place-des-tests-antigeniques-tag-sarscov-2-pour-le-depistage-pre-interventionnel/. positive PCR or antigen test in fully vaccinated immunocompetent patients without respiratory symptoms and no or few other symptoms: isolated ENT symptoms, isolated rapidly resolving fever, isolated headache. On the other hand, awaiting results from studies focusing on vaccinated patients, a 6-week interval is still recommended in vaccinated patients who had Covid infection with respiratory symptoms (cough, dyspnea, polypnea), immune-depressed patients and non-vaccinated patients. The second guideline [https://sfar.org/positionnement-de-lasfar-sur-la-place-des-tests-antigeniques-tag-sars-cov-2-pour-ledepistage-pre-interventionnel/] concerns the role of antigens tests in preoperative screening when access to PCR is limited during epidemic surges, in terms of hardware and of human resources; some structures then resort to antigen tests for preoperative screening. The SFAR first points out that, in the literature, the various antigen tests available show only moderate sensitivity, ranging between 35% and 95% for a median around 70% [3]. Even so, sensitivity seems higher in symptomatic patients, those with high viral load, and adults (as compared to children) [https://sfar.org/positionnement-de-la-sfar-sur-la-place-destests-antigeniques-tag-sars-cov-2-pour-le-depistage-preinterventionnel/]. Sensitivity in symptomatic patients ranges between 70% and 95% for a median around 80%, compared to 35-75% for a median 50% in asymptomatic patients [https:// sfar.org/positionnement-de-la-sfar-sur-la-place-des-testsantigeniques-tag-sars-cov-2-pour-le-depistage-preinterventionnel/]. As preoperative screening mainly involves asymptomatic patients, antigen tests turn up many false negatives. Therefore the SFAR recommends PCR on nasopharyngeal swab, ideally within 24 h and at most 72 h of surgery, as gold standard. If PCR cannot be made available in priority for patients undergoing surgery, antigen testing may be used as an alternative in those patients for whom a false negative would be less consequential in view of their history and type of intended surgery. Finally, the SFAR recommends reserving antigen tests so far as possible for preoperative screening of patients matching the algorithm shown in Fig. 1 and Appendix 1 (Source: SFAR). The authors declare that they have no competing interest. -Type 1 diabetes -Sickle-cell disease -Severe combined immune deficiency -Stage 5 kidney failure with dialysis -Age 60-74 years -Male gender -Obesity: BMI ≥ 35 kg/m 2 -Material deprivation (precarity) -Diabetes with HbA1c ≥ 7.5% -Immunodepression, including HIV -Solid cancer diagnosed within 5 years (except cured colon cancer) -Grade A chemotherapy, radiotherapy within 6 months -Stage 3-5 kidney failure -Neurologic disease other than stroke -COBP, PHT, asthma treated by inhaled corticosteroids -Heart failure, peripheral arteriopathy, atrial fibrillation -Thromboembolic disease with PE -Osteoporotic fracture -Cirrhosis -Rheumatoid arthritis -Systemic lupus or psoriasis Very high risk (HR > 5) -Age ≥ 75 years -Down's syndrome -Stem-cell graft -Grade B or C chemotherapy -Kidney transplant -Syndromic dementia -Cerebral palsy Surgery After SARS-CoV-2 infection: wait 7 weeks!!!